Skip to main content

Opportunistic invasive fungal pathogen Macrophomina phaseolina prognosis from immunocompromised humans to potential mitogenic RBL with an exceptional and novel antitumor and cytotoxic effect

European Journal of Clinical Microbiology & Infectious Diseases volume 31, pages 101–107 (2012)Cite this article

Abstract

With the ever-increasing risk for fungal infections, one can no longer ignore fungi. It is imperative that clinical manifestations “presume fungus” with their epidemiologic and pathogenic features when evaluating a potentially infected patient. In the high-risk patient groups, fungi with intrinsic resistance to antifungal agents already exist, with a tendency to emerge as opportunistic pathogens. One of the smart pathogens is Macrophomina phaseolina, with the potential to disarm plant, animal, and human immunity. The response prophylaxis may vary from antifungal therapy and surgical measures to biochemical (Rhizoctonia bataticola lectin [RBL] with antitumor and cytotoxic nature) and gene therapeutics.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317

    PubMed  Article  Google Scholar 

  2. Marr KA, Carter RA, Crippa F, Wald A, Corey L (2002) Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34:909–917

    PubMed  Article  Google Scholar 

  3. Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, Kauffman CA, Hyslop N, Mangino JE, Chapman S, Horowitz HW, Edwards JE, Dismukes WE (2003) A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37:634–643

    PubMed  Article  Google Scholar 

  4. Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D (2003) Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37:1172–1177

    PubMed  Article  Google Scholar 

  5. Lin SJ, Schranz J, Teutsch SM (2001) Aspergillosis case–fatality rate: systematic review of the literature. Clin Infect Dis 32:358–366

    PubMed  CAS  Article  Google Scholar 

  6. Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, Harrison LH, Seaberg EC, Hajjeh RA, Teutsch SM (2005) Excess mortality, hospital stay, and cost due to candidemia: a case–control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 26:540–547

    PubMed  Article  Google Scholar 

  7. Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K, Beney J (2002) The direct cost and incidence of systemic fungal infections. Value Health 5:26–34

    PubMed  Article  Google Scholar 

  8. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C (2005) The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41:1232–1239

    PubMed  Article  Google Scholar 

  9. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP (2002) Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989–1999. Clin Infect Dis 35:627–630

    PubMed  CAS  Article  Google Scholar 

  10. Baddley JW, Stroud TP, Salzman D, Pappas PG (2001) Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 32:1319–1324

    PubMed  CAS  Article  Google Scholar 

  11. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S (1997) The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24:1122–1128

    PubMed  CAS  Article  Google Scholar 

  12. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33:177–186

    PubMed  CAS  Article  Google Scholar 

  13. Kauffman CA (2001) Fungal infections in older adults. Clin Infect Dis 33:550–555

    PubMed  CAS  Article  Google Scholar 

  14. Kaufman D, Fairchild KD (2004) Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 17:638–680

    PubMed  Article  Google Scholar 

  15. Roilides E, Farmaki E, Evdoridou J, Dotis J, Hatziioannidis E, Tsivitanidou M, Bibashi E, Filioti I, Sofianou D, Gil-Lamaignere C, Mueller FM, Kremenopoulos G (2004) Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis 23:745–750

    PubMed  CAS  Article  Google Scholar 

  16. Vento S, Cainelli F (2003) Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol 4:595–604

    PubMed  Article  Google Scholar 

  17. Pfaller MA, Diekema DJ (2004) Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 42:4419–4431

    PubMed  CAS  Article  Google Scholar 

  18. Tan DHS, Sigler L, Gibas CFC, Fong IW (2008) Disseminated fungal infection in a renal transplant recipient involving Macrophomina phaseolina and Scytalidium dimidiatum: case report and review of taxonomic changes among medically important members of the Botryosphaeriaceae. Med Mycol 46:285–292

    PubMed  CAS  Article  Google Scholar 

  19. Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E (2004) Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 10(Suppl 1):48–66

    PubMed  Article  Google Scholar 

  20. Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP (2005) Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 41:60–66

    PubMed  Article  Google Scholar 

  21. Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW (2004) Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 42:1519–1527

    PubMed  Article  Google Scholar 

  22. Reingold AL, Lu XD, Plikaytis BD, Ajello L (1986) Systemic mycoses in the United States, 1980–1982. J Med Vet Mycol 24:433–436

    PubMed  CAS  Article  Google Scholar 

  23. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL (1998) The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992–1993: results of population-based laboratory active surveillance. Clin Infect Dis 27:1138–1147

    PubMed  CAS  Article  Google Scholar 

  24. Mihail JD (1992) Macrophomina. In: Singleton LL, Mihail JD, Rush CM (eds) Methods for research on soilborne phytopathogenic fungi. American Phytopathological Society Press, St. Paul, MN, pp 134–136

    Google Scholar 

  25. Crous PW, Slippers B, Wingfield MJ, Rheeder J, Marasas WFO, Philips AJL, Alves A, Burgess T, Barber P, Groenewald JZ (2006) Phylogenetic lineages in the Botryosphaeriaceae. Stud Mycol 55:235–253

    PubMed  Article  Google Scholar 

  26. Sharma S, Vandana, Ghoshal SK, Arora P, Dilbaghi N, Chaudhury A (2009) Study of optical properties of Macrophomina phaseolina impregnated sol-gel derived silica matrices. Appl Biochem Biotechnol 159:310–316

    PubMed  CAS  Article  Google Scholar 

  27. Srinivasan A, Wickes BL, Romanelli AM, Debelenko L, Rubnitz JE, Sutton DA, Thompson EH, Fothergill AW, Rinaldi MG, Hayden RT, Shenep JL (2009) Cutaneous infection caused by Macrophomina phaseolina in a child with acute myeloid leukemia. J Clin Microbiol 47:1969–1972

    PubMed  Article  Google Scholar 

  28. Bagyalakshmi R, Therese KL, Prasanna S, Madhavan HN (2008) Newer emerging pathogens of ocular non-sporulating molds (NSM) identified by polymerase chain reaction (PCR)-based DNA sequencing technique targeting internal transcribed spacer (ITS) region. Curr Eye Res 33:139–147

    PubMed  CAS  Article  Google Scholar 

  29. Hasegawa T, Yoshida Y, Kosuge J, Haga T, Goto Y, Shinjo T, Uchida K, Yamaguchi R, Tateyama S, Takatori K (2005) Subcutaneous granuloma associated with Macrophomina species infection in a cat. Vet Rec 156:23–24

    PubMed  CAS  Google Scholar 

  30. Muller Z, Chou KC, Nah KC (1975) Cassava as a total substitute for cereals in livestock and poultry rations. In: Proceedings of the 1974 Tropical Products Institute Conference, 1–5 April 1974, pp 85–95

  31. Ackerman MJ (1998) Consultation with the specialist: the long QT syndrome. Pediatr Rev 19:232–238

    PubMed  CAS  Article  Google Scholar 

  32. Scott DW, Miller WH, Griffin CE (2001) Neoplastic and non-neoplastic tumors. In: Scott DW, Miller WH, Griffin CE (eds) Muller and Kirk’s small animal dermatology, 6th edn. WB Saunders, Philadelphia, pp 1346–1357

    Google Scholar 

  33. Ng TB (2004) Peptides and proteins from fungi. Peptides 25:1055–1073

    PubMed  CAS  Article  Google Scholar 

  34. Candy L, Van Damme EJM, Peumans WJ, Menu-Bouaouiche L, Erard M, Rougé P (2003) Structural and functional characterization of the GalNAc/Gal-specific lectin from the phytopathogenic ascomycete Sclerotinia sclerotiorum (Lib.) de Bary. Biochem Biophys Res Commun 308:396–402

    PubMed  CAS  Article  Google Scholar 

  35. Khan F, Ahmad A, Khan MI (2007) Purification and characterization of a lectin from endophytic fungus Fusarium solani having complex sugar specificity. Arch Biochem Biophys 457:243–251

    PubMed  CAS  Article  Google Scholar 

  36. Tronchin G, Esnault K, Sanchez M, Larcher G, Marot-Leblond A, Bouchara J-P (2002) Purification and partial characterization of a 32-kilodalton sialic acid-specific lectin from Aspergillus fumigatus. Infect Immun 70:6891–6895

    PubMed  CAS  Article  Google Scholar 

  37. Guillot J, Konska G (1997) Lectins in higher fungi. Biochem Syst Ecol 25:203–230

    CAS  Article  Google Scholar 

  38. Thakur A, Rana M, Lakhanpal TN, Ahmad A, Khan M (2007) Purification and characterization of lectin from fruiting body of Ganoderma lucidum: lectin from Ganoderma lucidum. Biochim Biophys Acta 1770:1404–1412

    PubMed  CAS  Article  Google Scholar 

  39. Wang HX, Ng TB (2003) Isolation of a novel N-acetylglucosamine-specific lectin from fresh sclerotia of the edible mushroom Pleurotus tuber-regium. Protein Expr Purif 29:156–160

    PubMed  CAS  Google Scholar 

  40. Bhowal J, Guha AK, Chatterjee BP (2005) Purification and molecular characterization of a sialic acid specific lectin from the phytopathogenic fungus Macrophomina phaseolina. Carbohydr Res 340:1973–1982

    PubMed  CAS  Article  Google Scholar 

  41. Khan F, Islam Khan M (2011) Fungal lectins: current molecular and biochemical perspectives. Int J Biol Chem 5(1):1–20

    CAS  Article  Google Scholar 

  42. Sharon N, Lis H (2004) History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology 14:53R–62R

    PubMed  CAS  Article  Google Scholar 

  43. Rudd PM, Wormald MR, Stanfield RL, Huang M, Mattsson N, Speir JA, DiGennaro JA, Fetrow JS, Dwek RA, Wilson IA (1999) Roles for glycosylation of cell surface receptors involved in cellular immune recognition. J Mol Biol 293:351–366

    PubMed  CAS  Article  Google Scholar 

  44. Nangia-Makker P, Conklin J, Hogan V, Raz A (2002) Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents. Trends Mol Med 8:187–192

    PubMed  CAS  Article  Google Scholar 

  45. Gabius HJ, Wosgien B, Hendrys M, Bardosi A (1991) Lectin localization in human nerve by biochemically defined lectin-binding glycoproteins, neoglycoprotein and lectin-specific antibody. Histochemistry 95:269–277

    PubMed  CAS  Article  Google Scholar 

  46. Miyoshi N, Koyama Y, Katsuno Y, Hayakawa S, Mita T, Ohta T, Kaji K, Isemura M (2001) Apoptosis induction associated with cell cycle dysregulation by rice bran agglutinin. J Biochem 130:799–805

    PubMed  CAS  Google Scholar 

  47. Licastro F, Morini MC, Kretz O, Dirheimer G, Creppy EE, Stirpe F (1993) Mitogenic activity and Immunological properties of bolesatine, a lectin isolated from the mushroom Boletus satanas Lenz. Int J Biochem 25:789–792

    PubMed  CAS  Article  Google Scholar 

  48. Mahajan RG, Patil SI, Mohan DRK, Shastry P (2002) Pleurotus eous mushroom lectin (PEL) with mixed carbohydrate inhibition and antiproliferative activity on tumor cell lines. J Biochem Mol Biol Biophys 6(5):341–345

    PubMed  CAS  Article  Google Scholar 

  49. Zhao JK, Wang HX, Ng TB (2009) Purification and characterization of a novel lectin from the toxic wild mushroom Inocybe umbrinella. Toxicon 53(3):360–366

    PubMed  CAS  Article  Google Scholar 

  50. Wang HX, Liu WK, Ng TB, Ooi VEC, Chang ST (1996) The immunomodulatory and antitumor activities of lectins from the mushroom Tricholoma mongolicum. Immunopharmacology 31:205–211

    PubMed  CAS  Article  Google Scholar 

  51. Trigueros V, Lougarre A, Ali-ahmed D, Rahbé Y, Guillot J, Chavant L, Fournier D, Paquereau L (2003) Xerocomus chrysenteron lectin: identification of a new pesticidal protein. Biochim Biophys Acta 1621:292–298

    PubMed  CAS  Article  Google Scholar 

  52. Nagre NN, Chachadi VB, Sundaram PM, Naik RS, Pujari R, Shastry P, Swamy BM, Inamdar SR (2010) A potent mitogenic lectin from the mycelia of a phytopathogenic fungus, Rhizoctonia bataticola, with complex sugar specificity and cytotoxic effect on human ovarian cancer cells. Glycoconj J 27:375–386

    PubMed  CAS  Article  Google Scholar 

  53. Leonidas DD, Swamy BM, Hatzopoulos GN, Gonchigar SJ, Chachadi VB, Inamdar SR, Zographos SE, Oikonomakos NG (2007) Structural basis for the carbohydrate recognition of the Sclerotium rolfsii lectin. J Mol Biol 368:1145–1161

    PubMed  CAS  Article  Google Scholar 

  54. Nakamura-Tsuruta S, Kominami J, Kamei M, Koyama Y, Suzuki T, Isemura M, Hirabayashi J (2006) Comparative analysis by frontal affinity chromatography of oligosaccharide specificity of GlcNAc-binding lectins, Griffonia simplicifolia lectin-II (GSL-II) and Boletopsis leucomelas lectin (BLL). J Biochem 140:285–291

    PubMed  CAS  Article  Google Scholar 

  55. Paaventhan P, Joseph JS, Seow SV, Vaday S, Robinson H, Chua KY, Kolatkar PR (2003) A 1.7A structure of Fve, a member of the new fungal immunomodulatory protein family. J Mol Biol 332:461–470

    PubMed  CAS  Article  Google Scholar 

  56. Rosén S, Bergström J, Karlsson KA, Tunlid A (1996) A multispecific saline-soluble lectin from the parasitic fungus Arthrobotrys oligospora. Similarities in the binding specificities compared with a lectin from the mushroom Agaricus bisporus. Eur J Biochem 238:830–837

    PubMed  Article  Google Scholar 

  57. She QB, Ng TB, Liu WK (1998) A novel lectin with potent immunomodulatory activity isolated from both fruiting bodies and cultured mycelia of the edible mushroom Volvariella volvacea. Biochem Biophys Res Commun 247:106–111

    PubMed  CAS  Article  Google Scholar 

  58. Jeurink PV, Noguera CL, Savelkoul HF, Wichers HJ (2008) Immunomodulatory capacity of fungal proteins on the cytokine production of human peripheral blood mononuclear cells. Int Immunopharmacol 8:1124–1133

    PubMed  CAS  Article  Google Scholar 

  59. Romagnani S (1999) Th1/Th2 cells. Inflamm Bowel Dis 5:285–294

    PubMed  CAS  Article  Google Scholar 

  60. Matsuda S, Moriguchi T, Koyasu S, Nishida E (1998) T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J Biol Chem 273:12378–12382

    PubMed  CAS  Article  Google Scholar 

  61. Roy S, Chapin RB, Cain KJ, Charboneau RG, Ramakrishnan S, Barke RA (1997) Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes. Cell Immunol 179:1–9

    PubMed  CAS  Article  Google Scholar 

  62. Whitehurst CE, Boulton TG, Cobb MH, Geppert TD (1992) Extracellular signal-regulated kinases in T cells. Anti-CD3 and 4 beta-phorbol 12-myristate 13-acetate-induced phosphorylation and activation. J Immunol 148:3230–3237

    PubMed  CAS  Google Scholar 

  63. Ihle JN (2001) The Stat family in cytokine signaling. Curr Opin Cell Biol 13:211–217

    PubMed  CAS  Article  Google Scholar 

  64. Aaronson DS, Horvath CM (2002) A road map for those who don’t know JAK-STAT. Science 296:1653–1655

    PubMed  CAS  Article  Google Scholar 

  65. Valentino L, Pierre J (2006) JAK/STAT signal transduction: regulators and implication in hematological malignancies. Biochem Pharmacol 71:713–721

    PubMed  CAS  Article  Google Scholar 

  66. Pujari R, Nagre NN, Chachadi VB, Inamdar SR, Swamy BM, Shastry P (2010) Rhizoctonia bataticola lectin (RBL) induces mitogenesis and cytokine production in human PBMC via p38 MAPK and STAT-5 signaling pathways. Biochim Biophys Acta 1800:1268–1275. doi:10.1016/j.bbagen.2010.09.003

    PubMed  CAS  Article  Google Scholar 

  67. Brenchley JM, Douek DC, Ambrozak DR, Chatterji M, Betts MR, Davis LS, Koup RA (2002) Expansion of activated human naïve T-cells precedes effector function. Clin Exp Immunol 130:432–440

    PubMed  CAS  Article  Google Scholar 

  68. Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD, O’Shea JJ (1995) Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci USA 92:8705–8709

    PubMed  CAS  Article  Google Scholar 

  69. Gonsky R, Deem RL, Bream J, Young HA, Targan SR (2004) Enhancer role of STAT5 in CD2 activation of IFN-gamma gene expression. J Immunol 173:6241–6247

    PubMed  CAS  Google Scholar 

  70. Lafont V, Dornand J, Covassin L, Liautard JP, Favero J (1996) The lectin jacalin triggers CD4-mediated lymphocyte signaling by binding CD4 through a protein–protein interaction. J Leukoc Biol 59:691–696

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Ms. Pooja Arora gratefully acknowledges the Council of Scientific and Industrial Research (CSIR), Government of India, for providing the Senior Research Fellowship.

Author information

Affiliations

  1. Department of Bio and Nano Technology, Guru Jambheshwar University of Science and Technology, Hisar, 125001, Haryana, India

    P. Arora, N. Dilbaghi & A. Chaudhury

Authors
  1. P. Arora
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Dilbaghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Chaudhury
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Chaudhury.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Arora, P., Dilbaghi, N. & Chaudhury, A. Opportunistic invasive fungal pathogen Macrophomina phaseolina prognosis from immunocompromised humans to potential mitogenic RBL with an exceptional and novel antitumor and cytotoxic effect. Eur J Clin Microbiol Infect Dis 31, 101–107 (2012). https://doi.org/10.1007/s10096-011-1275-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-011-1275-1

Keywords

  • Internal Transcribe Spacer
  • Invasive Fungal Infection
  • Opportunistic Mycosis
  • Fungal Lectin
  • Mitogenic Lectin